CST7 and myeloid sarcoma: Expression patterns of cystatin F overlap in demyelinating regions undergoing remyelination in pre-clinical mouse models of demyelination and in plaques from patients with multiple sclerosis (MS), garnering new interest in cystatin F for its potential impact on neuroinflammation, immune-mediated demyelination, and remyelination [31–34].